Cell-cycle deregulation in BALB/c 3T3 cells transformed by 1,2-dibromoethane and folpet pesticides

Environmental and Molecular Mutagenesis

Volumn 41, Issue 5, 2003, Pages 315-321

  Santucci, Maria Alessandra ^a,b   Mercatali, Laura ^a   Brusa, Gianluca ^a   Pattacini, Laura ^a   Barbieri, Enza ^a   Perocco, Paolo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

1,2 dibromoethane; Cell cycle checkpoints; Cyclin; Folpet; Neoplastic transformation; Pesticides

Indexed keywords

1,2 DIBROMOETHANE; CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; FOLPET; PESTICIDE; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL TRANSFORMATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME INHIBITION; GENE OVEREXPRESSION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TRANSFORMED; CYCLIN A; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; ETHYLENE DIBROMIDE; FIBROBLASTS; G1 PHASE; MICE; MICE, INBRED BALB C; PESTICIDES; PHTHALIMIDES; S PHASE; TUMOR SUPPRESSOR PROTEINS;

EID: 0037974557     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.10162     Document Type: Article

References (62)

1. Adatia R, Albini A, Colacci A, De Giovanni C, Nanni P, Giunciulo D, Parodi S, Grilli S, Perocco P. 1993. Induction of chemotactic and invasive phenotype in BALB/c 3T3 cells by 1,2-dibromoethane transformation. Invasive Med 13:234-243.
2. Agrawal D, Hauser P, McPherson F, Dong F, Garcia A, Pledger WJ. 1996. Repression of p27 Kip1 synthesis by platelet-derived growth factor in BALB/C 3T3 cells. Mol Cell Biol 16:4327-4336.
3. Cip1/Waf1 proteins following γ-irradiation of human lymphoma cells. Cancer Res 55:2387-2393.
4. Braunstein JD, Halwer M. 1986. Brandford protein assay and determination of estrogen and progesterone receptors. Clin Chem 32:1588-1589.
5. Colacci A, Perocco P, Vaccari M, Da Vià C, Silingardi P, Manzini E, Horn W, Bartoli S, Grilli S. 1995. 1,2-Dibromoethane as an initiating agent for cell transformation. Jpn Cancer Res 86:168-173.
6. Colacci A, Vaccari M, Perocco P, Da Vià C, Silingardi P, Manzini E, Horn W, Grilli S. 1996. Enhancement of BALB/c 3T3 cells transformation by 1,2-dibromoethane promoting effect. Carcinogenesis 17:225-231.
7. Di Ilio C, Sacchetta P, Angelucci S, Bucciarelli T, Pennelli A, Mazzetti AP, Lo Bello M, Aceto A. 1996. Interaction of glutathione transferase P1-1 with captan and captafol. Biochem Pharmacol 52:43-48.
8. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K. 2000. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97:10002-10007.
9. Dulic V, Lees E, Reed SI. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958-1961.
10. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ, Reed SI. 1994. P53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
11. Dulic V, Beney GE, Frebourg G, Drullinger LF, Stein GH. 2000. Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol Cell Biol 18:6741-6754.
12. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
13. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y. 1994. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174.
14. Elledge SJ. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1172.
15. Furuno N, den Elzen N, Pinez J. 1999. Human cyclin A is required for mitosis until mid prophase. J Cell Biol 147:295-306.
16. Giaccia AJ, Kastan MB. 1998. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12:2973-2983.
17. Gu Y, Rosenblatt J, Morgan DO. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J 11:3995-4005.
18. Guadagno TM, Newport JW. 1996. Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 84:73-82.
19. Guo N, Faller DV, Vaziri C. 2000. A novel DNA damage checkpoint involving post-transcriptional regulation of cyclin A expression. J Biol Chem 275:1715-1722.
20. Halnet S, Helbig R, Hartmann A, Lang M, Seidel A, Speit G. 1997. A comparative investigation of DNA adducts, DNA strand breaks and gene mutations induced by benzo[a]pyrene-7,8-diol 9,10-oxide in cultured human cells. Mutat Res 390:179-188.
21. Hartwell LH, Kastan MB. 1994. Cell cycle control and cancer. Science 266:1821-1828.
22. Helin K, Harlow E, Fattaey A. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol 13: 6501-6508.
23. Henglein B, Chenivesse X, Wang J, Eick D, Brechot C. 1994. Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci USA 91:5490-5494.
24. IARC/NCI/EPA Working Group. 1985. Cellular and molecular mechanism of cell transformation and standardization of transformation assay of estabilished cell lines for the prediction of carcinogenetic chemicals: overview and recommended protocols. Cancer Res 45:2395-2399.
25. Innocente SA, Abrahamson JL, Cogswell JP, Lee JM. 1999. P53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci USA 96:2147-2152.
26. Jin P, Hardy S, Morgan DO. 1998. Nuclear localization of cyclin B1 controls mitotic entry after DNA damage. J Cell Biol 141:875-885.
27. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr JC. 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7:331-342.
28. Koff A, Giordano A, Desay D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM. 1992. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689-1694.
29. Krause K, Wasner M, Reinhard W, Haugwitz U, Dohna CL, Mossner J, Engeland K. 2000. The tumor suppressor protein p53 can repress transcription of cyclin B. Nucleic Acid Res 28:4410-4418.
30. Larner JM, Lee H, Hamlin JL. 1994. Radiation effects on DNA synthesis in a defined chromosomal replicon. Mol Cell Biol 14:1901-1908.
31. Liao C, Wang XY, Wei HQ, Li SQ, Merghoub T, Pandolfi PP, Wolgemuth DJ. 2001. Altered mielopoiesis and the development of acute myeloid leukemia in transgenic mice overexpressing cyclin Al. Proc Natl Acad Sci USA 98:6853-6858.
32. 6-alkylguanine-DNA alkyltransferase. J Biol Chem 277:37920-37928.
33. Lock LF, Pines J, Hunter T, Gilbert DJ, Gopalan G, Jenkins NA, Copeland NG, Donovan PJ. 1992. A single cyclin A gene and multiple cyclin B1-related sequences are dispersed in the mouse genome. Genomics 13:415-424.
34. Lukas C, Sorensen CS, Kramer E, Santoni-Rugiu E, Lindeneg C, Peters JM, Bartek J, Lukas J. 1999. Accumulation of cyclin B1 require E2F and cyclin A-dependent rearrangement of the anaphase-promoting complex. Nature 401:1815-1818.
35. Medema RH, Kops JG, Bos JL, Burgering BM. 2000. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782-787.
36. Morgan DO. 1997. Cyclin-dependent kinases: engines, clocks, and microprocessor. Annu Rev Cell Dev Biol 13:261-291.
37. Nasmyth K. 1996. Viewpoint: putting the cell cycle in order. Science 274:1643-1645.
38. Niculescu AB 3rd, Chen X, Smeets M, Hengst L, Prives C, Reed SI. 1998. Effects of p21 (Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 18:629-643.
39. Ortega S, Malumbres M, Babacid M. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602:73-87.
40. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J 11:961-971.
41. Pagano M, Pepperkok R, Lukas J, Baldin V, Ansorge W, Bartek J, Draetta G. 1993. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 121:101-111.
42. Passalaris TM, Benanti JA, Gewin L, Kiyono T, Galloway DA. 1999. The G(2) checkpoint is maintained by redundant pathways. Mol Cell Biol 19:5872-5881.
43. Paulovich AG, Toczyski DP, Hartwell L. 1997. When checkpoints fail. Cell 88:315-321.
44. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H. 1997. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277:1501-1505.
45. Perocco P, Colacci A, Del Ciello C, Grilli S. 1995. Transformation of BALB/c 3T3 cells in vitro by the fungicides Captan, Captafol and Folpet. Jpn J Cancer Res 86:941-947.
46. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
47. Rahden-Staron I. 2002. The inhibitory effect of the fungicides captan and captafol on eukaryotic topoisomerases in vitro and lack of recombinagenic activity in the wing spot test of Drosophila melanogaster. Mutat Res 518:205-213.
48. Rakitsky VN, Koblyakov VA, Turusov VS. 2000. Nongenotoxic (epigenetic) carcinogens: pesticides as an example. A critical review. Teratog Carcinog Mutagen 20:229-240.
49. 1-to-S transition. Mol Cell Biol 15:3463-3469.
50. Resnitzky D, Gossen M, Bujard H, Reed SI. 1994. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14:1669-1679.
51. Roberts JM. 1999. Evolving ideas about cyclins. Cell 98:129-32.
52. Rosenblatt J, Gu Y, Morgan DO. 1992. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc Natl Acad Sci USA 89:2824-2828.
53. Sherr CJ. 2000. The Petzcoller Lecture. Cancer cell cycle revised. Cancer Res 60:3689-3695.
54. Shirane M, Harumiya Y, Ishida H, Hiray A, Miyamoto C, Hatakeyama S, Nakayama K, Kitagawa M. 1999. Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 274:13886-13893.
55. Stahe L, Wold S. 1986. On the use of some multivariate statistical methods in pharmacological research. J Pharmacol Methods 16:91-110.
56. Stillman B. 1996. Cell cycle control of DNA replication. Science 274: 1659-1664.
57. Kip1 cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 93:4167-4178.
58. Toyoshima H, Hunter T. 1994. P27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
59. Toyoshima F, Moriguchi T, Wada A, Fukuda M, Nishida E. 1998. Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint. EMBO J 17:2728-2735.
60. Vlach J, Hennecke S, Amati B. 1997. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J 16: 5334-5344.
61. Weinert T. 1998. DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell 94:555-558.
62. Wimmel A, Lucibello FC, Sewing A, Adolph S, Muller S. 1994. Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 9:995-997.